Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease.
The regional distribution of immunoassayable thyrotropin releasing hormone (TRH) was determined in several regions of control and parkinsonian human brain. In Parkinson Disease the peptide content was not modified suggesting that TRH systems are not affected.